Your session is about to expire
← Back to Search
Passive Robotic Device
ExoNET for Stroke
N/A
Waitlist Available
Research Sponsored by Shirley Ryan AbilityLab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Hemiparesis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up tested at week 1 (baseline evaluations), week 4 (post evaluations), and week 9 (follow-up evaluations)
Awards & highlights
Study Summary
This trial will test a new robot device to help people with chronic stroke retrain their movement. The robot will help by compensating for gravity.
Who is the study for?
This trial is for adults who have had a stroke at least 8 months ago and now experience moderate arm weakness (hemiparesis). They should be able to move their shoulder and elbow somewhat but can't join if they have pain or stiffness in the joints, severe muscle tightness, recent Botox treatments in the arm, or problems with understanding that would affect participation.Check my eligibility
What is being tested?
The study is testing ExoNET, a passive robotic device designed to help support the arm during therapy exercises. It aims to see if it's safe and practical for people recovering from a stroke to use this device as part of their rehabilitation.See study design
What are the potential side effects?
Since ExoNET is non-invasive and supports movement without motors or electricity, side effects are expected to be minimal. However, participants may experience discomfort due to new movements or adjustments made by the device.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have weakness on one side of my body.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ tested at week 1 (baseline evaluations), week 4 (post evaluations), and week 9 (follow-up evaluations)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~tested at week 1 (baseline evaluations), week 4 (post evaluations), and week 9 (follow-up evaluations)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Upper arm
Secondary outcome measures
Box and Blocks
Fugl-Meyer
Wolf Motor Function Test
Other outcome measures
Electromyography using Delsys
Kinect
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Experimental Group: Gravity CompensationExperimental Treatment1 Intervention
The participants will be wearing the ExoNet device tuned to gravity support.
Group II: Control Group: No Gravity CompensationPlacebo Group1 Intervention
The participants will be wearing the ExoNet device, but it will not be tuned to gravity support.
Find a Location
Who is running the clinical trial?
Shirley Ryan AbilityLabLead Sponsor
192 Previous Clinical Trials
14,865 Total Patients Enrolled
69 Trials studying Stroke
6,325 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have moderate muscle stiffness.I had a stroke more than 8 months ago.You have a moderate impairment, with a Fugl-Meyer score between 15 and 50.I have shoulder pain or stiffness in my arm joint.I am under 18 years old.I have weakness in both sides of my body.I have weakness on one side of my body.I do not have speech, thinking, or mood problems that would affect my participation.I have received a Botox injection in my arm within the last 4 months.You have medical records and X-ray or scan results showing where the lesions are in your body.I can move both my shoulders and elbows.
Research Study Groups:
This trial has the following groups:- Group 1: Control Group: No Gravity Compensation
- Group 2: Experimental Group: Gravity Compensation
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor in need of participants?
"According to the public medical database, clinicaltrials.gov, this trial is currently seeking participants; its original posting on March 1st 2022 and most recent revisions of April 14th have been registered there."
Answered by AI
How many applicants are being considered for enrollment in this trial?
"Affirmative. The clinical trial is actively enlisting participants, as evidenced by the information available on clinicialtrials.gov which indicates that the study was initially made public on March 1st 2022 and last updated a month later in April 14th 2022. At this time, 20 patients must be recruited from one location for data collection purposes."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger